A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib

Clinical trial NCT07362940 · RECRUITING

Trial details

NCT number: NCT07362940
Sponsor: Henan Genuine Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-11-27
Primary completion: 2027-07-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.